STEVE ASELAGE - 31 Aug 2021 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Director
Signature
/s/ Alane P. Barnes by power of attorney
Issuer symbol
BCRX
Transactions as of
31 Aug 2021
Net transactions value
+$4,999
Form type
4
Filing time
02 Sep 2021, 16:28:26 UTC
Previous filing
01 Jun 2021
Next filing
08 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Award $4,999 +314 +0.98% $15.92 32,444 31 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $10,000.